# A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes

> **NCT04929379** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Alessandro Doria** · enrollment: 40 (estimated)

## Conditions studied

- Diabetic Nephropathies

## Interventions

- **DRUG:** Fenofibrate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04929379
- **Lead sponsor:** Alessandro Doria
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-04
- **Primary completion:** 2025-05-01
- **Final completion:** 2026-10-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04929379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04929379, "A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04929379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*